Amyris Inc. (Nasdaq: AMRS) narrowed losses for the fourth quarter significantly as revenue surged. Shares of the industrial bioscience company rose 82 cents to close at $6.40.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|